Beijing; Silicon Valley
Dr. Xiang Wang is the Asia Managing Partner and the head of Orrick’s China IP practice, splitting his time between three offices: Shanghai, Silicon Valley and Beijing, where he is the Managing Partner.
Xiang has extensive experience in assisting local and foreign-based multinational companies with all aspects of their IP rights in the US, China and Asia, including IP litigation and arbitration, patent infringement, Section 337 U.S. International Trade Commission (ITC) investigations, IP due diligence and portfolio counseling, industrial espionage, trade secrets misappropriation, mass torts and product liability, securities litigation, the Foreign Corrupt Practices Act (FCPA), the Alien Tort Statute (ATCA) and the Racketeer Influenced, patent office proceedings including inter partes reviews (IPR), and Corrupt Organizations Act (RICO) investigations and compliance. These matters have implicated a vast array of technologies, from software and electronics to renewable energy and medical devices as well as agricultural and building materials, to name just a few.
Xiang has been particularly active in advising Chinese state-owned enterprises on U.S. litigation. Clients turn to his strategic and innovative advice thanks to the in-depth understanding of their business needs and political risks.
Xiang has developed the region’s premier IP practice based on his reputation as one of the few IP lawyers who has a doctorate in electrical and computer engineering, a Chinese Certificate of Laws and admission to practice law in New York, Indiana and before the U.S. Patent and Trademark Office. Due to its success in patent disputes in both litigation and arbitration involving foreign companies in China, Orrick China IP team was exclusively featured in a documentary film “Patent Wars” by the China Central Television (CCTV).
Xiang is highly regarded for his practical legal advice that results from more than 10 years of experience at medical and electronic device businesses before becoming a lawyer. He also has received four U.S. medical-technology patents in his name.